Receive our newsletter – data, insights and analysis delivered to you
  1. Uncategorised
December 17, 2021updated 07 Jan 2022 8:47am

Coronavirus company news summary – FDA grants EUA to Applied BioCode’s combined Covid-19/flu/RSV test – Three Covid-19 tests fail to identify Omicron variant, FDA finds

By Kezia Parkins

The US Food and Drug Administration (FDA) has granted Emergency Use Authorization (EUA) to Applied BioCode’s multiplex molecular diagnostic assay for Covid-19 flu and Respiratory Syncytial Virus detection. The BioCode CoV-2 Flu Plus Assay can identify and distinguish between the SARS-CoV-2, Influenza A with subtypes RSV from nasopharyngeal swab samples. Intended to aid doctors in assessing individuals with clinical signs and symptoms of respiratory infection, this PCR test is the third test of the company to receive FDA EUA for Covid-19.

Ethos Laboratories has introduced its Tru-Immune, a self-collectable fingerstick kit for its Covid-19 neutralising antibody test offering quantitative data on the viral blocking ability neutralising antibodies. This test aids people to get immunity levels against Covid-19 rapidly and efficiently in real-time with minimum discomfort. Tru-Immune requires a simple drop of capillary blood from the fingertip and delivers results electronically in 48 hours.

The US Food and Drug Administration (FDA) has found that three Covid-19 molecular tests failed to identify the Omicron variant of the SARS-CoV-2 virus. The impacted tests are Revogene SARS-CoV-2 of Meridian Bioscience, Tide Laboratories’ DTPM COVID-19 RT-PCR Test and Linea COVID-19 Assay Kit of Applied DNA Sciences. The regulatory agency has advised halting the usage of these tests until the issues are addressed.

Related Companies

Content from our partners
The added value of Qarad’s multilingual freephone service to their eIFU solution
Small and simple: how medical device manufacturers select materials
Precision wire: The future of bespoke medical treatment
Topics in this article:
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. The top stories of the day delivered to you every weekday. A weekly roundup of the latest news and analysis, sent every Friday. The medical device industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU